Punch & Associates Investment Management, Inc. Landec Corp \Ca\ Transaction History

Punch & Associates Investment Management, Inc.

  • $1.62 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.0 - $9.95 $0 - $529,937
53,260 Added 7.36%
776,460 $0
Q3 2022

Nov 14, 2022
BUY
$8.57 - $11.57 $2.85 Million - $3.84 Million
332,165 Added 84.95%
723,200 $6.43 Million
Q2 2022

Aug 15, 2022
SELL
$8.84 - $11.64 $211,505 - $278,498
-23,926 Reduced 5.77%
391,035 $3.9 Million
Q1 2022

May 16, 2022
BUY
$10.07 - $11.93 $3.18 Million - $3.76 Million
315,519 Added 317.29%
414,961 $4.81 Million
Q4 2021

Feb 15, 2022
BUY
$7.95 - $11.24 $790,563 - $1.12 Million
99,442 New
99,442 $1.1 Million

Others Institutions Holding LNDC

# of Institutions
76
Shares Held
20.3M
Call Options Held
79.7K
Put Options Held
31.6K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email